World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
51
Citations
8454
World Ranking
4160
National Ranking
164

Hester E. de Melker publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hester E. de Melker sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 226 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Hester E. de Melker D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hester E. de Melker sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 51 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Hester E. de Melker is affiliated with the National Institute of Public Health and the Environment (RIVM) in the Netherlands. Their research primarily focuses on medicine and social sciences, with significant contributions in epidemiology, infectious diseases, and health. Additional subfields include modeling and simulation as well as clinical psychology.

The scientist's work addresses several main topics, including vaccine coverage and hesitancy, SARS-CoV-2 and COVID-19 research, COVID-19 epidemiological studies, and influenza virus research. Other areas of study include cervical cancer and HPV research, COVID-19 clinical research, and bacterial infections and vaccines.

Recent publications illustrate the scope of their work:

  • Increase in invasive group A streptococcal (Streptococcus pyogenes) infections (iGAS) in young children in the Netherlands, 2022 (2023, Eurosurveillance)
  • Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave (2020, Journal of Epidemiology & Community Health)
  • Impact of physical distancing measures against COVID-19 on contacts and mixing patterns: repeated cross-sectional surveys, the Netherlands, 2016-17, April 2020 and June 2020 (2021, Eurosurveillance)
  • Associations Between Measures of Social Distancing and Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity: A Nationwide Population-based Study in the Netherlands (2021, Clinical Infectious Diseases)
  • Early COVID-19 vaccine effectiveness of XBB.1.5 vaccine against hospitalisation and admission to intensive care, the Netherlands, 9 October to 5 December 2023 (2024, Eurosurveillance)

Frequent coauthors in their research include:

  • Mirjam J. Knol
  • Susan Hahné
  • Brechje de Gier
  • Gerco den Hartog
  • Susan van den Hof

Publication venues where Hester E. de Melker has contributed multiple papers include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Vaccine
  • Eurosurveillance
  • The Journal of Infectious Diseases
  • BMC Public Health

Best Publications

  • Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data.

    H. E. de Melker;J. F. P. Schellekens;S. E. Neppelenbroek;F. R. Mooi

  • Specificity and Sensitivity of High Levels of Immunoglobulin G Antibodies against Pertussis Toxin in a Single Serum Sample for Diagnosis of Infection with Bordetella pertussis

    H. E. de Melker;F. G. A. Versteegh;M. A. E. Conyn-van Spaendonck;L. H. Elvers

  • Why parents refuse childhood vaccination: a qualitative study using online focus groups

    Irene A Harmsen;Liesbeth Mollema;Robert A C Ruiter;Theo G W Paulussen

  • The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region.

    A. Nardone;F. de Ory;M. Carton;D. Cohen

  • Waning of Maternal Antibodies Against Measles, Mumps, Rubella, and Varicella in Communities With Contrasting Vaccination Coverage

    Sandra Waaijenborg;Susan J. M. Hahné;Liesbeth Mollema;Gaby P. Smits

  • Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis

    Sabine C. de Greeff;Hester E. de Melker;Pieter G. M. van Gageldonk;Joop F. P. Schellekens

  • The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys.

    Hester E de Melker;Florens G A Versteegh;Joop F P Schellekens;Peter F M Teunis

  • Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine.

    de Melker He;Conyn-van Spaendonck Ma;Rümke Hc;van Wijngaarden Jk

  • Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands.

    Gerwin D. Rodenburg;Sabine C. de Greeff;Angelique G. C. S. Jansen;Hester E. de Melker

  • The seroepidemiology of Bordetella pertussis infection in Western Europe.

    R. G. Pebody;A. Giammanco;S. Baron

  • The sero-epidemiology of diphtheria in Western Europe

    W. J. Edmunds;R. G. Pebody;H. Aggerback;S. Baron

  • Disease detection or public opinion reflection? content analysis of tweets, other social media, and online newspapers during the measles outbreak in the Netherlands in 2013

    Liesbeth Mollema;Irene A Harmsen;Emma Broekhuizen;Rutger Clijnk

  • Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the netherlands

    Sabine C. de Greeff;Hester E. de Melker;Lodewijk Spanjaard;Leo M. Schouls

  • The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.

    Hester E de Melker;Guy A M Berbers;Susan J M Hahné;Hans Rümke

  • Determinants for HPV vaccine uptake in the Netherlands: a multilevel study.

    Marc Rondy;Alies van Lier;Jan van de Kassteele;Laura Rust

  • Seroprevalence of trichodysplasia spinulosa-associated polyomavirus.

    Els van der Meijden;Siamaque Kazem;Manda M. Burgers;Rene Janssens

  • Increase in invasive group A streptococcal (Streptococcus pyogenes) infections (iGAS) in young children in the Netherlands, 2022

    Unknown

  • Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications.

    M.J. Korndewal;L. Mollema;I. Tcherniaeva;F. van der Klis

  • Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older : A systematic review

    Marlies Weltevrede;Renske Eilers;Hester E. de Melker;Debbie van Baarle

  • Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave.

    Eric R A Vos;Gerco den Hartog;Rutger M Schepp;Patricia Kaaijk

  • Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009–2012

    Jussi Sane;Sigrid Gouma;Marion Koopmans;Hester de Melker

  • Rubella outbreak in the Netherlands, 2004-2005: high burden of congenital infection and spread to Canada.

    Susan Hahné;Jeannette Macey;Rob van Binnendijk;Robert Kohl

  • Long-term impairment attributable to congenital cytomegalovirus infection: a retrospective cohort study

    Marjolein J Korndewal;H M Anne Marie Oudesluys-Murphy;Aloys C M Kroes;Marianne A B van der Sande

  • Consistency between stated and revealed preferences: a discrete choice experiment and a behavioural experiment on vaccination behaviour compared

    Mattijs S. Lambooij;Irene A. Harmsen;Jorien Veldwijk;Hester de Melker

  • Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands

    Anna M. M. van Deursen;Suzan P. van Mens;Elisabeth A. M. Sanders;Bart J. M. Vlaminckx

  • Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage

    Susan van den Hof;Guy A.M. Berbers;Hester E. de Melker;Marina A.E. Conyn-van Spaendonck

  • Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study

    Mirjam J Knol;Susan J M Hahné;Jay Lucidarme;Helen Campbell

  • Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands.

    Mirjam J Knol;Gertjan H J Wagenvoort;Elisabeth A M Sanders;Karin Elberse

  • Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine.

    Richarda M. de Voer;Richarda M. de Voer;Liesbeth Mollema;Rutger M. Schepp;Sabine C. de Greeff

  • Effect of vaccination programmes on mortality burden among children and young adults in the Netherlands during the 20th century: a historical analysis

    Maarten van Wijhe;Scott A McDonald;Hester E de Melker;Maarten J Postma;Maarten J Postma

Frequent Co-Authors

Elisabeth A. M. Sanders
Elisabeth A. M. Sanders Utrecht University
Guy A. M. Berbers
Guy A. M. Berbers University of Minnesota
Arie van der Ende
Arie van der Ende University of Amsterdam
Chris J.L.M. Meijer
Chris J.L.M. Meijer Vrije Universiteit Amsterdam
Robert A. C. Ruiter
Robert A. C. Ruiter Maastricht University
Frits R. Mooi
Frits R. Mooi National Institute of Public Health and the Environment (RIVM)
Maarten J. Postma
Maarten J. Postma University of Groningen
Gerjo Kok
Gerjo Kok Maastricht University
Leo M. Schouls
Leo M. Schouls University of Minnesota
Marion Koopmans
Marion Koopmans Erasmus University Rotterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare degrees can open diverse career pathways. Many students consider nursing as a gateway into immunology-focused roles. Finding the easy LPN programs to get into can be an excellent starting point for gaining foundational clinical experience in patient care.

Advancing beyond LPN, easy nurse practitioner programs to get into offer streamlined options for nurses aiming to specialize, often including immunology-related subjects within their curriculum.

Psychiatric mental health nurse practitioner (PMHNP) programs are another pathway that intersects with immunology, especially in understanding the impact of immune functions on mental health. Prospective students should consider programs like the best PMHNP programs, which offer strong clinical placements to enhance hands-on learning.

For those seeking cost-effective options, the cheapest online PMHNP certificate programs provide affordable pathways to certification without compromising quality education.

Best Scientists Citing Hester E. de Melker

Trending Scientists

Recently Published Articles